HR 5950
117th Congress
House
Crime and Law Enforcement
Improving Patient Access to Care and Treatment Act
Introduced: November 12, 2021
Introduced by:
Dean, Madeleine
Democratic
· Pennsylvania
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Nov 15, 2021
Referred to the Subcommittee on Health.
Nov 12, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 12, 2021
Introduced in House
Plain-English summary
Improving Patient Access to Care and Treatment Act
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Committees of jurisdiction
4